Midkine, a newly discovered regulator of the renin-angiotensin pathway in mouse aorta: Significance of the pleiotrophin/midkine developmental gene family in angiotensin II signaling

Biochemical and Biophysical Research Communications

Volumn 333, Issue 2, 2005, Pages 636-643

  Ezquerra, Laura ^a,b   Herradon, Gonzalo ^a,b   Nguyen, Trang ^b,c   Silos Santiago, Inmaculada ^b,c   Deuel, Thomas F ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b MILLENNIUM PHARMACEUTICALS INC   (United States)

^c VERTEX PHARMACEUTICALS   (United States)

Author keywords

Cancer; Development; Midkine; Pleiotrophin; Renin angiotensin

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSINOGEN; DIPEPTIDYL CARBOXYPEPTIDASE; MESSENGER RNA; MIDKINE; PLEIOTROPHIN; RENIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; MALE; MOUSE; MULTIGENE FAMILY; NONHUMAN; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SIGNAL TRANSDUCTION; WILD TYPE;

ANGIOTENSIN II; ANIMALS; AORTA; CARRIER PROTEINS; CYTOKINES; GENE EXPRESSION REGULATION; MICE; RENIN-ANGIOTENSIN SYSTEM; SIGNAL TRANSDUCTION;

EID: 20544469178     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2005.05.113     Document Type: Article

References (72)

1. P.G. Milner, Y.S. Li, R.M. Hoffman, C.M. Kodner, N.R. Siegel, and T.F. Deuel A novel 17 kD heparin-binding growth factor (HBGF-8) in bovine uterus: purification and N-terminal amino acid sequence Biochem. Biophys. Res. Commun. 165 1989 1096 1103
2. Y.S. Li, P.G. Milner, A.K. Chauhan, M.A. Watson, R.M. Hoffman, C.M. Kodner, J. Milbrandt, and T.F. Deuel Cloning and expression of a developmentally regulated protein that induces mitogenic and neurite outgrowth activity Science 250 1990 1690 1694
3. H. Rauvala An 18-kD heparin-binding protein of developing brain that is distinct from fibroblast growth factors EMBO J. 8 1989 2933 2941
4. J.M. Vanderwinden, P. Mailleux, S.N. Schiffmann, and J.J. Vanderhaeghen Cellular distribution of the new growth factor pleiotrophin (HB-GAM) mRNA in developing and adult rat tissues Anat. Embryol. (Berl) 186 1992 387 406
5. I. Silos-Santiago, H.J. Yeh, M.A. Gurrieri, R.P. Guillerman, Y.S. Li, J. Wolf, W. Snider, and T.F. Deuel Localization of pleiotrophin and its mRNA in subpopulations of neurons and their corresponding axonal tracts suggests important roles in neural-glial interactions during development and in maturity J. Neurobiol. 31 1996 283 296
6. T.F. Deuel, N. Zhang, H.J. Yeh, I. Silos-Santiago, and Z.Y. Wang Pleiotrophin: a cytokine with diverse functions and a novel signaling pathway Arch. Biochem. Biophys. 397 2002 162 171
7. K. Kadomatsu, M. Tomomura, and T. Muramatsu cDNA cloning and sequencing of a new gene intensely expressed in early differentiation stages of embryonal carcinoma cells and in mid-gestation period of mouse embryogenesis Biochem. Biophys. Res. Commun. 151 1988 1312 1318
8. S. Matsubara, M. Take, C. Pedraza, and T. Muramatsu Mapping and characterization of a retinoic acid-responsive enhancer of midkine, a novel heparin-binding growth/differentiation factor with neurotrophic activity J. Biochem. (Tokyo) 115 1994 1088 1096
9. M. Michikawa, S. Kikuchi, H. Muramatsu, T. Muramatsu, and S.U. Kim Retinoic acid responsive gene product, midkine, has neurotrophic functions for mouse spinal cord and dorsal root ganglion neurons in culture J. Neurosci. Res. 35 1993 530 539
10. H. Muramatsu, H. Shirahama, S. Yonezawa, H. Maruta, and T. Muramatsu Midkine, a retinoic acid-inducible growth/differentiation factor: immunochemical evidence for the function and distribution Dev. Biol. 159 1993 392 402
11. M. Nakamoto, S. Matsubara, T. Miyauchi, H. Obama, M. Ozawa, and T. Muramatsu A new family of heparin binding growth/differentiation factors: differential expression of the midkine (MK) and HB-GAM genes during mouse development J. Biochem. (Tokyo) 112 1992 346 349
12. T.A. Mitsiadis, M. Salmivirta, T. Muramatsu, H. Muramatsu, H. Rauvala, E. Lehtonen, M. Jalkanen, and I. Thesleff Expression of the heparin-binding cytokines, midkine (MK) and HB-GAM (pleiotrophin) is associated with epithelial-mesenchymal interactions during fetal development and organogenesis Development 121 1995 37 51
13. N. Zhang, and T.F. Deuel Pleiotrophin and midkine, a family of mitogenic and angiogenic heparin-binding growth and differentiation factors Curr. Opin. Hematol. 6 1999 44 50
14. G.E. Stoica, A. Kuo, C. Powers, E.T. Bowden, E.B. Sale, A.T. Riegel, and A. Wellstein Midkine binds to anaplastic lymphoma kinase (ALK) and acts as a growth factor for different cell types J. Biol. Chem. 277 2002 35990 35998
15. T. Pufe, M. Bartscher, W. Petersen, B. Tillmann, and R. Mentlein Expression of pleiotrophin, an embryonic growth and differentiation factor, in rheumatoid arthritis Arthritis Rheum. 48 2003 660 667
16. J. Courty, M.C. Dauchel, D. Caruelle, M. Perderiset, and D. Barritault Mitogenic properties of a new endothelial cell growth factor related to pleiotrophin Biochem. Biophys. Res. Commun. 180 1991 145 151
17. W. Fang, N. Hartmann, D.T. Chow, A.T. Riegel, and A. Wellstein Pleiotrophin stimulates fibroblasts and endothelial and epithelial cells and is expressed in human cancer J. Biol. Chem. 267 1992 25889 25897
18. K. Laaroubi, J. Delbe, F. Vacherot, P. Desgranges, M. Tardieu, M. Jaye, D. Barritault, and J. Courty Mitogenic and in vitro angiogenic activity of human recombinant heparin affin regulatory peptide Growth Factors 10 1994 89 98
19. N. Kaneda, A.H. Talukder, H. Nishiyama, S. Koizumi, and T. Muramatsu Midkine, a heparin-binding growth/differentiation factor, exhibits nerve cell adhesion and guidance activity for neurite outgrowth in vitro J. Biochem. (Tokyo) 119 1996 1150 1156
20. L. Ezquerra, G. Herradon, T. Nguyen, T.F. Vogt, R. Bronson, I. Silos-Santiago, and T.F. Deuel Pleiotrophin is a major regulator of the catecholamine biosynthesis pathway in mouse aorta Biochem. Biophys. Res. Commun. 323 2004 512 517
21. G. Herradon, L. Ezquerra, T. Nguyen, T.F. Vogt, R. Bronson, I. Silos-Santiago, and T.F. Deuel Pleiotrophin is an important regulator of the renin-angiotensin system in mouse aorta Biochem. Biophys. Res. Commun. 324 2004 1041 1047
22. M. Horiba, K. Kadomatsu, E. Nakamura, H. Muramatsu, S. Ikematsu, S. Sakuma, K. Hayashi, Y. Yuzawa, S. Matsuo, M. Kuzuya, T. Kaname, M. Hirai, H. Saito, and T. Muramatsu Neointima formation in a restenosis model is suppressed in midkine-deficient mice J. Clin. Invest. 105 2000 489 495
23. K. Hayashi, H. Banno, K. Kadomatsu, Y. Takei, K. Komori, and T. Muramatsu Antisense oligodeoxyribonucleotide as to the growth factor midkine suppresses neointima formation induced by balloon injury Am. J. Physiol. Heart Circ. Physiol. 2005
24. H.J. Yeh, Y.Y. He, J. Xu, C.Y. Hsu, and T.F. Deuel Upregulation of pleiotrophin gene expression in developing microvasculature, macrophages, and astrocytes after acute ischemic brain injury J. Neurosci. 18 1998 3699 3707
25. W.D. Beecken, W. Kramer, and D. Jonas New molecular mediators in tumor angiogenesis J. Cell Mol. Med. 4 2000 262 269
26. G.A. Mashour, N. Ratner, G.A. Khan, H.L. Wang, R.L. Martuza, and A. Kurtz The angiogenic factor midkine is aberrantly expressed in NF1-deficient Schwann cells and is a mitogen for neurofibroma-derived cells Oncogene 20 2001 97 105
27. N. Zhang, R. Zhong, Z.Y. Wang, and T.F. Deuel Human breast cancer growth inhibited in vivo by a dominant negative pleiotrophin mutant J. Biol. Chem. 272 1997 16733 16736
28. P. Mailleux, J.M. Vanderwinden, and J.J. Vanderhaeghen The new growth factor pleiotrophin (HB-GAM) mRNA is selectively present in the meningothelial cells of human meningiomas Neurosci. Lett. 142 1992 31 35
29. A. Nakagawara, J. Milbrandt, T. Muramatsu, T.F. Deuel, H. Zhao, A. Cnaan, and G.M. Brodeur Differential expression of pleiotrophin and midkine in advanced neuroblastomas Cancer Res. 55 1995 1792 1797
30. F. Czubayko, A.M. Schulte, G.J. Berchem, and A. Wellstein Melanoma angiogenesis and metastasis modulated by ribozyme targeting of the secreted growth factor pleiotrophin Proc. Natl. Acad. Sci. USA 93 1996 14753 14758
31. T. O'Brien, D. Cranston, S. Fuggle, R. Bicknell, and A.L. Harris The angiogenic factor midkine is expressed in bladder cancer, and overexpression correlates with a poor outcome in patients with invasive cancers Cancer Res. 56 1996 2515 2518
32. C. Ye, M. Qi, Q.W. Fan, K. Ito, S. Akiyama, Y. Kasai, M. Matsuyama, T. Muramatsu, and K. Kadomatsu Expression of midkine in the early stage of carcinogenesis in human colorectal cancer Br. J. Cancer 79 1999 179 184
33. D. Weber, H.J. Klomp, F. Czubayko, A. Wellstein, and H. Juhl Pleiotrophin can be rate-limiting for pancreatic cancer cell growth Cancer Res. 60 2000 5284 5288
34. R. Mentlein, and J. Held-Feindt Pleiotrophin, an angiogenic and mitogenic growth factor, is expressed in human gliomas J. Neurochem. 83 2002 747 753
35. P. Soulie, M. Heroult, I. Bernard, M.E. Kerros, P.E. Milhiet, J. Delbe, D. Barritault, D. Caruelle, and J. Courty Immunoassay for measuring the heparin-binding growth factors HARP and MK in biological fluids J. Immunoassay Immunochem. 23 2002 33 48
36. T. Nakanishi, K. Kadomatsu, T. Okamoto, Y. Tomoda, and T. Muramatsu Expression of midkine and pleiotropin in ovarian tumors Obstet. Gynecol. 90 1997 285 290
37. S.H. Koshizawa, T. Matsumura, Y. Kadono, T. Sawada, K. Kadomatsu, H. Muramatsu, and T. Muramatsu Alteration of midkine expression associated with chemically-induced differentiation in human neuroblastoma cells Cancer Lett. 111 1997 117 125
38. R. Jager, B. List, C. Knabbe, B. Souttou, D. Raulais, T. Zeiler, A. Wellstein, A. Aigner, A. Neubauer, and G. Zugmaier Serum levels of the angiogenic factor pleiotrophin in relation to disease stage in lung cancer patients Br. J. Cancer 86 2002 858 863
39. L. Yu, K. Hamada, M. Namba, K. Kadomatsu, T. Muramatsu, S. Matsubara, and M. Tagawa Midkine promoter-driven suicide gene expression and -mediated adenovirus replication produced cytotoxic effects to immortalised and tumour cells Eur. J. Cancer 40 2004 1787 1794
40. Y. Takei, K. Kadomatsu, K. Yuasa, W. Sato, and T. Muramatsu Morpholino antisense oligomer targeting human midkine: its application for cancer therapy Int. J. Cancer 114 2005 490 497
41. E. Nakamura, K. Kadomatsu, S. Yuasa, H. Muramatsu, T. Mamiya, T. Nabeshima, Q.W. Fan, K. Ishiguro, T. Igakura, S. Matsubara, T. Kaname, M. Horiba, H. Saito, and T. Muramatsu Disruption of the midkine gene (Mdk) resulted in altered expression of a calcium binding protein in the hippocampus of infant mice and their abnormal behaviour Genes Cells 3 1998 811 822
42. L.E. Amet, S.E. Lauri, A. Hienola, S.D. Croll, Y. Lu, J.M. Levorse, B. Prabhakaran, T. Taira, H. Rauvala, and T.F. Vogt Enhanced hippocampal long-term potentiation in mice lacking heparin-binding growth-associated molecule Mol. Cell. Neurosci. 17 2001 1014 1024
43. K. Takeda, O. Takeuchi, T. Tsujimura, S. Itami, O. Adachi, T. Kawai, H. Sanjo, K. Yoshikawa, N. Terada, and S. Akira Limb and skin abnormalities in mice lacking IKKalpha Science 284 1999 313 316
44. A.R. Brasier, and J. Li Mechanisms for inducible control of angiotensinogen gene transcription Hypertension 27 1996 465 475
45. C.G. Chen, J. Malliaros, M. Katerelos, A.J. d'Apice, and M.J. Pearse Inhibition of NF-kappaB activation by a dominant-negative mutant of IkappaBalpha Mol. Immunol. 33 1996 57 61
46. K. Tamura, S. Umemura, N. Nyui, M. Yabana, Y. Toya, A. Fukamizu, K. Murakami, and M. Ishii Possible role of c-Jun in transcription of the mouse renin gene Kidney Int. 54 1998 382 393
47. L. Pan, and K.W. Gross Transcriptional regulation of renin: an update Hypertension 45 2005 3 8
48. A.A. Duffy, M.M. Martin, and T.S. Elton Transcriptional regulation of the AT1 receptor gene in immortalized human trophoblast cells Biochim. Biophys. Acta 1680 2004 158 170
49. R. Shimizu-Hirota, H. Sasamura, M. Mifune, H. Nakaya, M. Kuroda, M. Hayashi, and T. Saruta Regulation of vascular proteoglycan synthesis by angiotensin II type 1 and type 2 receptors J. Am. Soc. Nephrol. 12 2001 2609 2615
50. Y. Sumi, H. Muramatsu, Y. Takei, K. Hata, M. Ueda, and T. Muramatsu Midkine, a heparin-binding growth factor, promotes growth and glycosaminoglycan synthesis of endothelial cells through its action on smooth muscle cells in an artificial blood vessel model J. Cell Sci. 115 2002 2659 2667
51. K. Egami, T. Murohara, T. Shimada, K. Sasaki, S. Shintani, T. Sugaya, M. Ishii, T. Akagi, H. Ikeda, T. Matsuishi, and T. Imaizumi Role of host angiotensin II type 1 receptor in tumor angiogenesis and growth J. Clin. Invest. 112 2003 67 75
52. E. Escobar, T.S. Rodriguez-Reyna, O. Arrieta, and J. Sotelo Angiotensin II, cell proliferation and angiogenesis regulator: biologic and therapeutic implications in cancer Curr. Vasc. Pharmacol. 2 2004 385 399
53. C.R. Burrow Retinoids and renal development Exp. Nephrol. 8 2000 219 225
54. T.D. Piscione, and N.D. Rosenblum The molecular control of renal branching morphogenesis: current knowledge and emerging insights Differentiation 70 2002 227 246
55. J. Vilar, C. Lalou, V.H. Duong, S. Charrin, S. Hardouin, D. Raulais, C. Merlet-Benichou, and M. Lelievre-Pegorier Midkine is involved in kidney development and in its regulation by retinoids J. Am. Soc. Nephrol. 13 2002 668 676
56. Y. Chen, D. Lasaitiene, and P. Friberg The renin-angiotensin system in kidney development Acta. Physiol. Scand. 181 2004 529 535
57. H. Obama, S. Biro, T. Tashiro, J. Tsutsui, M. Ozawa, H. Yoshida, H. Tanaka, and T. Muramatsu Myocardial infarction induces expression of midkine, a heparin-binding growth factor with reparative activity Anticancer Res. 18 1998 145 152
58. H.W. Chen, S.L. Yu, W.J. Chen, P.C. Yang, C.T. Chien, H.Y. Chou, H.N. Li, K. Peck, C.H. Huang, F.Y. Lin, J.J. Chen, and Y.T. Lee Dynamic changes of gene expression profiles during postnatal development of the heart in mice Heart 90 2004 927 934
59. S. Kojima, T. Inui, H. Muramatsu, T. Kimura, S. Sakakibara, and T. Muramatsu Midkine is a heat and acid stable polypeptide capable of enhancing plasminogen activator activity and neurite outgrowth extension Biochem. Biophys. Res. Commun. 216 1995 574 581
60. S. Kojima, H. Muramatsu, H. Amanuma, and T. Muramatsu Midkine enhances fibrinolytic activity of bovine endothelial cells J. Biol. Chem. 270 1995 9590 9596
61. K. Maruyama, H. Muramatsu, N. Ishiguro, and T. Muramatsu Midkine, a heparin-binding growth factor, is fundamentally involved in the pathogenesis of rheumatoid arthritis Arthritis Rheum. 50 2004 1420 1429
62. T. Takada, T. Kinkori, H. Muramatsu, A. Hayakawa, S. Torii, and T. Muramatsu Midkine, a retinoic acid-inducible heparin-binding cytokine, is a novel regulator of intracellular calcium in human neutrophils Biochem. Biophys. Res. Commun. 241 1997 756 761
63. M. Miyashiro, K. Kadomatsu, N. Ogata, C. Yamamoto, K. Takahashi, M. Uyama, H. Muramatsu, and T. Muramatsu Midkine expression in transient retinal ischemia in the rat Curr. Eye Res. 17 1998 9 13
64. N. Konishi, M. Nakamura, S. Nakaoka, Y. Hiasa, M. Cho, H. Uemura, Y. Hirao, T. Muramatsu, and K. Kadomatsu Immunohistochemical analysis of midkine expression in human prostate carcinoma Oncology 57 1999 253 257
65. N. Koide, H. Hada, T. Shinji, K. Ujike, S. Hirasaki, Y. Yumoto, T. Hanafusa, K. Kadomatsu, H. Muramatsu, T. Muramatsu, and T. Tsuji Expression of the midkine gene in human hepatocellular carcinomas Hepatogastroenterology 46 1999 3189 3196
66. S. Ikematsu, A. Yano, K. Aridome, M. Kikuchi, H. Kumai, H. Nagano, K. Okamoto, M. Oda, S. Sakuma, T. Aikou, H. Muramatsu, K. Kadomatsu, and T. Muramatsu Serum midkine levels are increased in patients with various types of carcinomas Br. J. Cancer 83 2000 701 706
67. M. Kato, H. Maeta, S. Kato, T. Shinozawa, and T. Terada Immunohistochemical and in situ hybridization analyses of midkine expression in thyroid papillary carcinoma Mod. Pathol. 13 2000 1060 1065
68. K.M. Ahmed, Y. Shitara, S. Takenoshita, H. Kuwano, S. Saruhashi, and T. Shinozawa Association of an intronic polymorphism in the midkine (MK) gene with human sporadic colorectal cancer Cancer Lett. 180 2002 159 163
69. K. Kadomatsu, and T. Muramatsu Midkine and pleiotrophin in neural development and cancer Cancer Lett. 204 2004 127 143
70. Y. Takei, K. Kadomatsu, S. Matsuo, H. Itoh, K. Nakazawa, S. Kubota, and T. Muramatsu Antisense oligodeoxynucleotide targeted to Midkine, a heparin-binding growth factor, suppresses tumorigenicity of mouse rectal carcinoma cells Cancer Res. 61 2001 8486 8491
71. H. Yoshiji, S. Kuriyama, and H. Fukui Angiotensin-I-converting enzyme inhibitors may be an alternative anti-angiogenic strategy in the treatment of liver fibrosis and hepatocellular carcinoma. Possible role of vascular endothelial growth factor Tumour Biol. 23 2002 348 356
72. A. Molteni, W.F. Ward, C.H. Ts'ao, J. Taylor, W. Small, Jr., L. Brizio-Molteni, and P.A. Veno Cytostatic properties of some angiotensin I converting enzyme inhibitors and of angiotensin II type I receptor antagonists Curr. Pharm. Des. 9 2003 751 761